A Phase 3, Randomized, Open-Label, Multicenter Study, to Compare T-Guard to Ruxolitinib for the Treatment of Patients with Grade III or IV Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD) BMT CTN Protocol #2002
Clinical Trial Grant
Awarded By
National Marrow Donor Program
Start Date
May 18, 2022
End Date
July 31, 2025
Awarded By
National Marrow Donor Program
Start Date
May 18, 2022
End Date
July 31, 2025